Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"Galantamine"”.

  1. Long Term Outcome and Prediction Models of Cognition, Activities of Daily Living and Nursing Home Placement in Alzheimer’s Disease with Cholinesterase Inhibitor Treatment

    … patients treated with donepezil, rivastigmine or galantamine III. 790 patients treated with donepezil, rivastigmine or galantamine IV. 880 patients treated with donepezil, rivastigmine or galantamine Results I. Regression models predicted 3-year cognitive outcome in ChEI-treated patients with high …

    lund Repository record for Long Term Outcome and Prediction Models of Cognition, Activities of Daily Living and Nursing Home Placement in Alzheimer’s Disease with Cholinesterase Inhibitor Treatment (opens in a new tab)

  2. Influence of a Nicotinic Treatment on Auditory Sensory Processing in Schizophrenia

    … with selective α7 nAChR agonist properties and galantamine, a nAChR positive allosteric modulator (PAM), which was posited to augment α7 nAChR signalling. Auditory sensory processing was examined with ERP paradigms assessing two functions commonly impaired in SCZ; (a) the ability to inhibit …

    ottawa-retro Repository record for Influence of a Nicotinic Treatment on Auditory Sensory Processing in Schizophrenia (opens in a new tab)

  3. Long-term treatment response, predictors and biochemical markers in Alzheimer’s disease.

    … (ChEIs) (tacrine, donepezil, rivastigmine, galantamine) were introduced as treatments for AD. Multiple short-term randomised clinical trials of ChEI treatment show beneficial effects on cognition, global functioning and activities of daily living in AD. Whether the effects of long-term ChEI …

    lund Repository record for Long-term treatment response, predictors and biochemical markers in Alzheimer’s disease. (opens in a new tab)

  4. Changes in cerebral glucose metabolism in patients with Parkinson’s disease with dementia after cholinesterase inhibitor therapy

    … Patients were treated with either donepezil or galantamine. End point was when patients were treated for at least 3 months and when the patient or family members reported improved cognition. 18F-FDG PET scan was done before initiation of treatment and after completion drug trial. SPM images were …

    ajou Repository record for Changes in cerebral glucose metabolism in patients with Parkinson’s disease with dementia after cholinesterase inhibitor therapy (opens in a new tab)

  5. CUMULATIVE ANTICHOLINERGIC BURDEN AND ASSOCIATED OUTCOMES AMONG OLDER ADULTS WITH ALZHEIMER’S DISEASE

    … any of the ChEIs (donepezil, rivastigmine, or galantamine). The cumulative anticholinergic burden was calculated based on the Anticholinergic Cognitive Burden scale and patient-specific dosing using the defined daily dose over the defined period after ChEIs initiation. For objective 1, the …

    houston Repository record for CUMULATIVE ANTICHOLINERGIC BURDEN AND ASSOCIATED OUTCOMES AMONG OLDER ADULTS WITH ALZHEIMER’S DISEASE (opens in a new tab)

  6. Natural Products Chemistry of Leads Acting on MRSA, HCV, Malaria, and Depression Disorders

    … (foxglove) for treatment of heart disease, galantamine from Galanthus caucasicus (snowdrops) for treatment of Alzheimer's disease, and paclitaxel from the bark of the Pacific yew tree to treat cancer. </p> <p>During the course of these studies, we researched the potential of natural products …

    mississippi Repository record for Natural Products Chemistry of Leads Acting on MRSA, HCV, Malaria, and Depression Disorders (opens in a new tab)